The Small Business Administration (SBA) 8(a) Sole Source vehicle enables agencies to engage in direct buy contracts with certified contractors.
Genome International holds the National Institutes of Health Chief Information Officer-Solutions and Partners (CIO-SP3) GWAC as part of a JV. Our 8(a) Disadvantaged Small Business Group Contract #HHSN316201200106W.
This certification formally acknowledges that Genome International Corporation is an independent woman-owned company. The certification no 2005112300 includes a review of Genome International Corporation's professional, legal, and financial status
The advent of Next Generation Sequencing (NGS) has revolutionized life science research by accelerating discovery in agricultural, pharmaceutical and biomedical sectors. The cost of massively parallel DNA sequencing has been decreasing at an unbelievable rate over the past decade enabling the routine sequencing of genomes, transcriptomes, exomes, methylomes, and microRNAomes. However, analysis, interpretation and knowledge discovery is limited by the availability of robust statistical data analysis software and skilled interdisciplinary scientists to analyze and interpret the results of such analyses. It is this huge unmet need that drives our scientists and engineers to innovate next-generation solutions based on cumulative knowledge and experience gained over the past decade.
GIC provides a highly scalable and automated platform that enables users to comprehensively and rapidly analyze their next-generation sequencing data. The user need not worry about any software or database installation. Various NGS applications and sequencing platforms are supported. On request, the workflows can be quickly customized as needed. The results of analysis are delivered as a detailed report.
